TAAR3: A Protein Target for Drug Development (G9288)

Target Name: TAAR3P

NCBI ID: G9288

TAAR3P

TAAR3: A Protein Target for Drug Development

Trace amine receptor 3 (TAAR3) is a protein that is expressed in various tissues throughout the body. It is a member of the superfamily of G protein-coupled receptors, which are a family of transmembrane proteins that play an important role in cellular signaling. TAAR3 is characterized by its extracellular domain, which consists of a single transmembrane alpha-helix.

TAAR3 is involved in a wide range of physiological processes in the body, including the regulation of neurotransmitter signaling, pain perception, and inflammation. It is also involved in the development and progression of various diseases, including cancer.

Due to its involvement in so many important physiological processes, TAAR3 has been identified as a potential drug target. Researchers are currently exploring the use of small molecules and other compounds to modulate TAAR3 activity and treat a variety of diseases.

One approach to targeting TAAR3 is to use small molecules that can modulate the activity of TAAR3. These molecules can either activate or inhibit TAAR3, depending on the specific function that they are intended to promote or inhibit. One example of a small molecule that can act as an inhibitor is the compound JS-6542, which is a selective TAAR3 inhibitor that blocks the interaction of TAAR3 with G protein-coupled receptors.

Another approach to targeting TAAR3 is to use antibodies that can selectively bind to TAAR3 and inhibit its activity. These antibodies can be used to treat a variety of diseases, including cancer. For example, researchers have developed an antibody that targets TAAR3 and has been shown to be effective in treating melanoma, a type of skin cancer.

In addition to small molecules and antibodies, researchers are also exploring the use of other approaches to modulate TAAR3 activity, such as gene editing and CRISPR-Cas9 technology. These approaches can be used to identify and modify the genetic material of cells, allowing researchers to create changes to the TAAR3 gene that may affect its activity.

Overall, TAAR3 is a protein that is involved in a wide range of important physiological processes in the body. As a result, it is an attractive target for drug development and research into the underlying mechanisms of various diseases. The use of small molecules and antibodies , as well as other approaches such as gene editing and CRISPR-Cas9 technology, offers the potential to further our understanding of TAAR3 and its role in the regulation of various physiological processes.

Protein Name: Trace Amine Associated Receptor 3, Pseudogene

The "TAAR3P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAAR3P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets